Approximately one-third of patients with Crohn's disease do not respond to conventional
treatments, and some experience significant adverse effects, such as serious infections and …

Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the intestine of unclear
etiology. Increasing evidence has pointed to intestinal dysbiosis as a potential factor in a …

Inflammatory bowel disease consists of disorders characterized by chronic idiopathic bowel
inflammation. The concept of host–gut–microbiome interaction in the pathogenesis of …

Inflammatory bowel disease (IBD) is due to an aberrant immune response toward luminal
antigens, probably commensal bacteria, in genetically susceptible subjects and is also …

There is increasing evidence of the key role played by altered intestinal microbiota in the
pathogenesis of inflammatory bowel disease (IBD). Management strategies involving …

Background The role of the gut microbiota in Crohn's disease (CD) is established and fecal
microbiota transplantation (FMT) is an attractive therapeutic strategy. No randomized …

The intestinal microbiota plays an important role in inflammatory bowel disease (IBD). The
pathogenesis of IBD involves inappropriate ongoing activation of the mucosal immune …

Inflammatory bowel disease (IBD) is a chronic multifactorial disease that affects the
gastrointestinal tract and results from an aberrant immune response toward luminal antigens …

Background The microbiota in the lumen of patients with Crohn's disease (CD) is
characterized by reduced diversity, particularly Firmicutes and Bacteroidetes. It is unknown …

One hypothesis for the etiology of inflammatory bowel disease is that an altered or
pathogenic microbiota causes inflammation in a genetically susceptible individual …